Xuege Wang
Overview
Explore the profile of Xuege Wang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
267
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang H, Li N, Liu Q, Guo J, Pan Q, Cheng B, et al.
Cancer Cell
. 2023 Jun;
41(7):1345-1362.e9.
PMID: 37352863
Lineage plasticity causes therapeutic resistance; however, it remains unclear how the fate conversion and phenotype switching of cancer-associated fibroblasts (CAFs) are implicated in disease relapse. Here, we show that androgen...
2.
Li N, Liu Q, Han Y, Pei S, Cheng B, Xu J, et al.
Nat Commun
. 2022 Nov;
13(1):7281.
PMID: 36435834
Chronic inflammation and an immunosuppressive microenvironment promote prostate cancer (PCa) progression and diminish the response to immune checkpoint blockade (ICB) therapies. However, it remains unclear how and to what extent...
3.
Wang X, Dong Y, Yu S, Mu G, Qu H, Li Z, et al.
Int J Environ Res Public Health
. 2022 Nov;
19(21).
PMID: 36361281
A municipal wastewater treatment plant plays an important role in treating urban sewage and reducing the quantity of pollutants discharged into rivers. However, the energy consumption of the municipal wastewater...
4.
Wang X, Yan F, Lyne V, Su F
Science
. 2022 Sep;
377(6611):1164.
PMID: 36074852
No abstract available.
5.
Ren J, Li N, Pei S, Lian Y, Li L, Peng Y, et al.
J Clin Invest
. 2022 Mar;
132(8).
PMID: 35230972
IFN-γ-stimulated MHC class I (MHC-I) antigen presentation underlies the core of antitumor immunity. However, sustained IFN-γ signaling also enhances the programmed death ligand 1 (PD-L1) checkpoint pathway to dampen antitumor...
6.
Chen M, Su F, Cheng F, Zhang Y, Wang X
Sci Rep
. 2021 Aug;
11(1):16553.
PMID: 34376785
No abstract available.
7.
Pan Q, Zhong S, Wang H, Wang X, Li N, Li Y, et al.
Mol Cell
. 2021 May;
81(13):2736-2751.e8.
PMID: 33932349
Cholesterol metabolism is tightly associated with colorectal cancer (CRC). Nevertheless, the clinical benefit of statins, the inhibitor of cholesterol biogenesis mevalonate (MVA) pathway, is inconclusive, possibly because of a lack...
8.
Cheng X, Zhao W, Zhu M, Wang B, Wang X, Yang X, et al.
Cancer Biol Med
. 2021 Apr;
PMID: 33893730
Objective: Drug repurposing, the application of existing therapeutics to new indications, holds promise in achieving rapid clinical effects at a much lower cost than that of drug development. The aim...
9.
Chen M, Su F, Cheng F, Zhang Y, Wang X
Sci Rep
. 2021 Feb;
11(1):3917.
PMID: 33594218
Coral reef islands provide precious living space and valuable ecological services for human beings, and its sustainability cannot be ignored under the pressure of human activities. Carrying capacity (CC) assessment...
10.
Yuan H, Han Y, Wang X, Li N, Liu Q, Yin Y, et al.
Cancer Cell
. 2020 Jul;
38(3):350-365.e7.
PMID: 32619406
The level of SETD2-mediated H3K36me3 is inversely correlated with that of EZH2-catalyzed H3K27me3. Nevertheless, it remains unclear whether these two enzymatic activities are molecularly intertwined. Here, we report that SETD2...